Document is current
Any future updates will be listed below
-
Authors
Westerink, Lotte https://orcid.org/0000-0001-9515-1044
Wolters, Sharon
Zhou, Guiling
Postma, Arjan
Boersma, Cornelis https://orcid.org/0000-0002-1190-2638
van Boven, Job Frank Martien https://orcid.org/0000-0003-2368-2262
Postma, Maarten Jacobus https://orcid.org/0000-0002-6306-3653
- License Information
-
More Information
Article History
Received: 12 October 2023
Accepted: 10 July 2024
First Online: 30 August 2024
Declarations
:
: LW is currently employed at AstraZeneca, this research has been performed unrelated to her work at AstraZeneca and is part of her PhD research at the University Medical Center Groningen, the Netherlands. LW is a previous employee (at time of research) of Asc Academics Inc. SW and AP are employees of Asc Academics BV. GZ has no conflict of interest. MP received grants and honoraria from various pharmaceutical companies, including companies interested in the subject of this paper. JB received consultancy fees, honorarium, and research funding from Aardex, AstraZeneca, Chiesi, GSK, Novartis, Pfizer, Pill Connect, Teva, Trudell Medical and Vertex to consult, give lectures, provide advice, and conduct independent research, all paid to his institution. CB received grants and honoraria from various pharmaceutical companies, including companies interested in the subject of this paper.
